BridgeMD
Compares treatment options for Discitis of Thoracic Region
Official title Parascapular Sub Iliocostalis Plane Block Versus Thoracic Paravertebral Plane Block for Traumatic Multiple Rib Fractures
ClinicalTrials.gov ID: NCT07493473
What this study is testing
- What it's testing
- Pain control of rib fractures is essential for not only primary pain relief but also preventing secondary complications such as atelectasis or pneumonia which increase the hospital stay, as well as the transition to chronic pain. The cornerstones of analgesic management are oral and intravenous medications such as paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids as well as regional block techniques as paravertebral block and thoracic epidural.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 60
You may be able to join if
- Patient written informed consent.
- ASA I to III.
- Age 21-60 years old.
- Gender: Both.
- BMI \< 35 Kg/M2.
You likely can't join if
- Any trauma in the patient that interfere with the positioning of patients for block.
- Patients who needed mechanical ventilation before or during the study.
- Patients with associated head trauma.
- Patient with hemodynamic instability and need inotropic support. Patient with abbreviated injury scale (AIS) in extremity more than 2 (10)
- Pathological coagulopathy.
- Infection at the injection site.
See the full eligibility criteria
- Patient written informed consent.
- ASA I to III.
- Age 21-60 years old.
- Gender: Both.
- BMI \< 35 Kg/M2.
- Accepted mental state of the patient.
- Patient with unilateral multiple rib fractures (≥2 fractures)
- Any trauma in the patient that interfere with the positioning of patients for block.
- Patients who needed mechanical ventilation before or during the study.
- Patients with associated head trauma.
- Patient with hemodynamic instability and need inotropic support. Patient with abbreviated injury scale (AIS) in extremity more than 2 (10)
- Pathological coagulopathy.
- Infection at the injection site.
- Disturbed conscious level.
- An allergy to local anesthetics or any used drugs in this study.
- Pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Zagazig, Sharqia Province, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zagazig, Sharqia Province, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.